Sargen Gregory

Sargen Gregory is listed in filings as Director at Protara Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 13, 2025, including 9 public disclosures. Recent filings connect the profile to Protara Therapeutics, Inc. (TARA) and Avid Bioservices, Inc. (CDMO). The current snapshot covers public activity from Dec 17, 2024 to Jun 13, 2025. Reported amounts are shown as $78.2K to $135.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.